Loading...
CRESCENT PHARMA LIMITED — Gliclazide Import Profile: Suppliers, Formulations & Sources
Loading...
Pharmaceutical Importer · #15 buyer for Gliclazide · $1.2M import value · 54 shipments · UNITED KINGDOM · DGFT Verified
CRESCENT PHARMA LIMITED is the #15 importer of Gliclazide from India with $1.2M in import value and 54 verified shipments. CRESCENT PHARMA LIMITED holds a 0.4% market share in Gliclazide imports based in UNITED KINGDOM. The company sources from 1 verified supplier across 35 formulations shipped to 1 country. Overall, CRESCENT PHARMA LIMITED imports 6 pharmaceutical products worth $11.8M across 5 therapeutic categories.
Verified from 54 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| UNISON PHARMACEUTICALS PRIVATE LIMITED | $1.2M | 54 | 100.0% |
CRESCENT PHARMA LIMITED sources Gliclazide from 1 verified Indian supplier based on 54 customs records. The primary supplier is UNISON PHARMACEUTICALS PRIVATE LIMITED accounting for 100.0% of imports.
Buyers ranked immediately above and below #15 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 12 | TORRENT DO BRASIL LIMITEDA | BRAZIL | $1.6M | 58 | $27.9K |
| 11 | SUN PHARMA CANADA INC. | CANADA | $1.4M | 27 | $50.0K |
| 15 | CRESCENT PHARMA LIMITED ★ | UNITED KINGDOM | $1.2M | 54 | $22.2K |
| 1 | MYLAN HUNGARY KFT, | HUNGARY | $1.1M | 21 | $50.0K |
| 2 | DANANG PHARMACEUTICAL MEDICAL EQUIP | VIETNAM | $1.1M | 21 | $50.0K |
CRESCENT PHARMA LIMITED ranks #15 among 643 Gliclazide importers from India. Average shipment value of $22.2K compared to the market average of $40.7K. The closest competitors by value are TORRENT DO BRASIL LIMITEDA and SUN PHARMA CANADA INC..
Destination countries from 54 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $1.2M | 54 | 100.0% |
CRESCENT PHARMA LIMITED imports Gliclazide to 1 country. The primary destination is UNITED KINGDOM receiving 100.0% of shipments worth $1.2M.
| Formulation | Value | Shipments |
|---|---|---|
| GLICLAZIDE 80 MG TABLETS (GLICLAZIDE)(2X14T)BL(GLICLAZIDE)B.NO.2330948 TO 2330952,2330997,2331022,2331023 AS PER INVOICENOS | $108.2K | 3 |
| GLICLAZIDE 80 MG TABLETS GLICLAZIDE 2 | $94.6K | 2 |
| GLICLAZIDE 80 MG TABLETS GLICLAZIDE BA | $94.5K | 2 |
| GLICLAZIDE 80 MG TABLETS (GLICLAZIDE) 2X 14 B.NO.: 2430233 TO 2430236 AS PER INVOICE | $54.8K | 3 |
| GLICLAZIDE 80 MG TABLETS (GLICLAZIDE) ( | $50.0K | 1 |
| GLICLAZIDE 80 MG TABLETS(2X14T)BL (GLICLAZIDE) B.No.: 2430246 2430309 2430310& 2430398 AS PER INVOICE | $50.0K | 1 |
| GLICLAZIDE 80 MG TABLETS (2X14T) BL(GLICLAZIDE)(1 NOS=1 PACK)(B. NO.2530089,2530090,2530091,2530092 & 2530136) (AS INV) | $50.0K | 1 |
| GLICLAZIDE 40 MG TABLETS(2x14T)BL (GLICLAZIDE) B.No.: 2530225,2530226 & 2530227MFG. DT: 02/2025 EXP. DT: 01/2027 (AS PE |
What CRESCENT PHARMA LIMITED and other importers must comply with to import Gliclazide from India
Medicines and Healthcare products Regulatory Agency (MHRA)
Marketing Authorisation via national procedure or Mutual Recognition. Post-Brexit, separate UK MA required independent of EU approval.
Typical timeline: 12–15 months for national procedure
UK GMP compliance; MHRA GMP inspection of manufacturing site
India exported $26.2M worth of Gliclazide through 3,830 shipments from 238 suppliers to 109 countries, serving 643 buyers globally. CRESCENT PHARMA LIMITED imports $1.2M of this total, accounting for 0.4% of India's Gliclazide exports with 54 shipments from UNITED KINGDOM. This is verified from 54 customs shipment records covering 35 distinct formulations.
CRESCENT PHARMA LIMITED's average Gliclazide order value is $21.7K per consignment, based on 54 shipments totaling $1.2M. CRESCENT PHARMA LIMITED is based in UNITED KINGDOM and ranks #15 among all Gliclazide importers from India by value. The company sources from 1 verified supplier in India.
CRESCENT PHARMA LIMITED sources Gliclazide from 1 verified Indian supplier: UNISON PHARMACEUTICALS PRIVATE LIMITED ($1.2M, 100.0%). This is based on 54 customs records.
CRESCENT PHARMA LIMITED ranks #15 among 643 Gliclazide importers from India with a 0.4% market share. The top 3 importers are TORRENT DO BRASIL LTDA ($6.5M), MEDREICH PLC ($3.1M), M/S. RANBAXY FARMACEUTICA LTDA : ($2.4M). CRESCENT PHARMA LIMITED processed 54 shipments from UNITED KINGDOM.
CRESCENT PHARMA LIMITED imports 6 products worth $11.8M. Beyond Gliclazide, top products include Ramipril, Levothyroxine, Terbinafine, Diazepam, Clonazepam. View the complete CRESCENT PHARMA LIMITED profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Gliclazide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Verify import regulations and drug registration requirements with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access order-level details, pricing data, supplier connections, and competitive analysis for CRESCENT PHARMA LIMITED's Gliclazide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CRESCENT PHARMA LIMITED
Full Company Profile →
6 products · $11.8M total trade · 5 categories
| $50.0K |
| 1 |
| GLICLAZIDE 80 MG TABLETS GLICLAZIDE -2X14 B.NO : 2330770 2330771 2330772 | $45.9K | 1 |
| GLICLAZIDE 80 MG TABLETS 2X14T BL GLICLAZIDE B No 2530507 2530512 2530513 DETAILS AS PER INVOICE | $32.6K | 1 |
CRESCENT PHARMA LIMITED imports 35 distinct Gliclazide formulations from India. The top formulation is GLICLAZIDE 80 MG TABLETS (GLICLAZIDE)(2X14T)BL(GLICLAZIDE)B. with 3 shipments worth $108.2K.
Manufacturer/Importer Authorisation (MIA) from MHRA; Qualified Person release required
UK-specific labeling; English language PIL; UK Marketing Authorisation number
Note: Post-Brexit, EU GMP certificates no longer automatically valid — separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available MHRA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with MHRA or qualified regulatory affairs professionals for case-specific guidance.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 109+ countries, 643+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Verified from customs records
Access shipment-level records, supplier contacts, and formulation details for CRESCENT PHARMA LIMITED.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Gliclazide. For current order-level data, contact TransData Nexus.